1. Home
  2. MPLT vs NBHC Comparison

MPLT vs NBHC Comparison

Compare MPLT & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$7.78

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

SELL

Current Price

$36.91

Market Cap

1.7B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
MPLT
NBHC
Founded
2018
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
MPLT
NBHC
Price
$7.78
$36.91
Analyst Decision
Strong Buy
Buy
Analyst Count
15
4
Target Price
$26.54
★ $45.00
AVG Volume (30 Days)
420.3K
★ 442.0K
Earning Date
12-03-2026
10-27-2026
Dividend Yield
N/A
★ 3.41%
EPS Growth
★ 82.39
N/A
EPS
N/A
★ 1.04
Revenue
N/A
★ $47,100,000.00
Revenue This Year
N/A
$26.12
Revenue Next Year
N/A
$7.22
P/E Ratio
★ N/A
$36.12
Revenue Growth
N/A
★ 2.86
52 Week Low
$7.85
$35.06
52 Week High
$40.43
$47.28

Technical Indicators

Market Signals
Indicator
MPLT
NBHC
Relative Strength Index (RSI) 22.05 24.48
Support Level N/A N/A
Resistance Level $20.46 $42.66
Average True Range (ATR) 0.58 0.68
MACD -0.04 -0.10
Stochastic Oscillator 11.14 2.17

Price Performance

Historical Comparison
MPLT
NBHC

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

Share on Social Networks: